Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Shibata

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Plos One|October 25, 2017
Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapyAkira Shibata, Masako Kuno, Ryutaro Adachi, et al.
Biochemical Pharmacology|January 26, 2018
Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonistAkira Shibata, Keiko Uga, Takayuki Sato, et al.
The Kurume Medical Journal|May 21, 2004
Risk of death due to hepatocellular carcinoma among drinkers and ex-drinkers. Univariate analysis of JACC study dataItsuro Ogimoto, Akira Shibata, Youichi Kurozawa, et al.
The Kurume Medical Journal|May 21, 2004
Risk of death due to hepatocellular carcinoma among smokers and ex-smokers. Univariate analysis of JACC study dataItsuro Ogimoto, Akira Shibata, Youichi Kurozawa, et al.
Marine Pollution Bulletin|October 6, 2005
Microbial responses using denaturing gradient gel electrophoresis to oil and chemical dispersant in enclosed ecosystemsAkihiro Yoshida, Hideaki Nomura, Keita Toyoda, et al.
Bioscience, Biotechnology, and Biochemistry|September 14, 2012
Physiological effects and tissue distribution from large doses of tocotrienol in ratsAkira Shibata, Kiyotaka Nakagawa, Hitoshi Shirakawa, et al.
International Journal of Hematology|April 9, 2005
Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphomaMayumi Mori, Kiyoshi Kitamura, Michihiko Masuda, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 12, 2019
Pharmacological effects of TAK-828F: an orally available RORγt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel diseaseKeiko Igaki, Yoshiki Nakamura, Masayuki Tanaka, et al.
Chemmedchem|October 30, 2019
Design and Synthesis of Conformationally Constrained RORγt Inverse AgonistsAyumu Sato, Yoshiyuki Fukase, Mitsunori Kono, et al.
International Journal of Hematology|February 5, 2011
Clinical value of assessing the response to imatinib monitored by interphase FISH and RQ-PCR for BCR-ABL in peripheral blood for long-term survival of chronic phase CML patients: results of the Niigata CML-multi-institutional co-operative clinical studyTatsuo Furukawa, Miwako Narita, Tadashi Koike, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Plos One|October 25, 2017
Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapyAkira Shibata, Masako Kuno, Ryutaro Adachi, et al.
Biochemical Pharmacology|January 26, 2018
Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonistAkira Shibata, Keiko Uga, Takayuki Sato, et al.
The Kurume Medical Journal|May 21, 2004
Risk of death due to hepatocellular carcinoma among drinkers and ex-drinkers. Univariate analysis of JACC study dataItsuro Ogimoto, Akira Shibata, Youichi Kurozawa, et al.
The Kurume Medical Journal|May 21, 2004
Risk of death due to hepatocellular carcinoma among smokers and ex-smokers. Univariate analysis of JACC study dataItsuro Ogimoto, Akira Shibata, Youichi Kurozawa, et al.
Marine Pollution Bulletin|October 6, 2005
Microbial responses using denaturing gradient gel electrophoresis to oil and chemical dispersant in enclosed ecosystemsAkihiro Yoshida, Hideaki Nomura, Keita Toyoda, et al.
Bioscience, Biotechnology, and Biochemistry|September 14, 2012
Physiological effects and tissue distribution from large doses of tocotrienol in ratsAkira Shibata, Kiyotaka Nakagawa, Hitoshi Shirakawa, et al.
International Journal of Hematology|April 9, 2005
Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphomaMayumi Mori, Kiyoshi Kitamura, Michihiko Masuda, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 12, 2019
Pharmacological effects of TAK-828F: an orally available RORγt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel diseaseKeiko Igaki, Yoshiki Nakamura, Masayuki Tanaka, et al.
Chemmedchem|October 30, 2019
Design and Synthesis of Conformationally Constrained RORγt Inverse AgonistsAyumu Sato, Yoshiyuki Fukase, Mitsunori Kono, et al.
International Journal of Hematology|February 5, 2011
Clinical value of assessing the response to imatinib monitored by interphase FISH and RQ-PCR for BCR-ABL in peripheral blood for long-term survival of chronic phase CML patients: results of the Niigata CML-multi-institutional co-operative clinical studyTatsuo Furukawa, Miwako Narita, Tadashi Koike, et al.
Pageof 8